Thrive Capital Management »

Iovance Biotherapeutics shares owned by Thrive Capital Management

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Thrive Capital Management from 13F filings

Historical chart of Thrive Capital Management investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Thrive Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Thrive Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $81k 10k 8.13
2023-09-30 $46k 10k 4.55

More positions owned by Thrive Capital Management

Ishares Tr Core Div Grwth (DGRO)
Vanguard Whitehall Fds High Div Yld (VYM)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Ishares Tr 0-5yr Hi Yl Cp (SHYG)
Global X Fds Nasdaq 100 Cover (QYLD)
Global X Fds S&p 500 Covered (XYLD)
Apple (AAPL)
Ishares Tr Modert Alloc Etf (AOM)
Vanguard Whitehall Fds Intl High Etf (VYMI)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Ishares Tr Conser Alloc Etf (AOK)
Spdr Ser Tr Portfolio Short (SPSB)
First Tr Nasdaq 100 Tech Ind SHS (QTEC)
Vanguard Index Fds Value Etf (VTV)
Wisdomtree Tr Intl Equity Fd (DWM)

View all positions for Thrive Capital Management

Top funds holding Iovance Biotherapeutics

Vanguard Group
MHR Fund Management
Perceptive Advisors
venBio Select Advisor
Artisan Partners Limited Partnership
OrbiMed Advisors
Susquehanna International
Balyasny Asset Management
Goldman Sachs Group
Dimensional Fund Advisors
T. Rowe Price Associates
Jpmorgan Chase & Co
Credit Suisse
Long Focus Capital Management
Palo Alto Investors

View all funds holding Iovance Biotherapeutics